(Q61933891)

English

A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus

clinical trial

Statements

A 1 Month, Open-Label Inpatient, Randomized Cross-Over Trial Assessing The Impact Of Dry Powder Inhaled Insulin (Exubera) On 24-Hour Glycemic Control Compared To Insulin Glargine (Lantus) In Patients With Type 2 Diabetes Mellitus Who Are Poorly Controlled On A Combination Of Two Oral Agents (English)
0 references
0 references
September 2006
0 references
30
0 references
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit